News archive for 2020

hepatitis virus

World Hepatitis Day: EMCDDA showcases hepatitis questionnaire for drug service staff to refresh knowledge and identify training needs

28.07.2020

Every year, on 28 July, the World Health Organization (WHO) and partners mark World Hepatitis Day to increase awareness and understanding of viral hepatitis and the diseases it causes. It is...

Stronger together: EU agencies join forces to respond to COVID-19

14.07.2020

Since the start of the COVID-19 pandemic, the nine JHA agencies (CEPOL, EASO, EIGE, EMCDDA, eu-LISA, Eurojust, Europol, FRA and Frontex) have been supporting the EU Member States and institutions in...

EMCDDA welcomes external partners to virtual event on lessons learned from the impact of COVID-19 on the drug situation in Europe

30.06.2020

The EMCDDA will be joined by a range of its external partners today in a virtual event following on from International day against drug abuse and illicit trafficking (26 June). The meeting is a...
microphone

Speech by Alexis Goosdeel: Closing remarks on the impact of the COVID-19 pandemic on the world drug situation — the European perspective

26.06.2020

Occasion: Closing remarks on the impact of the COVID-19 pandemic on the world drug situation — the European perspective Thank you Chairperson and colleagues,

EMCDDA and Europol join EU institutions in dialogue on the impact of COVID-19 on the world drug situation

26.06.2020

On the occasion of International day against drug abuse and illicit trafficking, the EMCDDA and Europol are joining representatives of the EU institutions today in providing the European perspective...
photo alexis goosdeel

EMCDDA Management Board renews mandate of Alexis Goosdeel

25.06.2020

The EMCDDA Management Board took the unanimous decision today to renew the mandate of the agency’s Director, Alexis Goosdeel, for the next five years. Mr Goosdeel took up the post of EMCDDA Director...
Computer-generated simulation of a corona virus (copyrighted)

COVID-19: New EMCDDA study highlights decline in stimulant drug use but some rises in the use of cannabis, alcohol and prescription medicines to combat anxiety and depression

23.06.2020

A decline in stimulant drug use but some rises in the consumption of cannabis and licit substances are among the findings presented today in a new EMCDDA report The impact of COVID-19 on patterns of...
Paper showing years with 2019 pinned

A year in review: General Report of Activities 2019 published

15.06.2020

New products and services, working in partnership, and support to policy and practice in the fields of health and security are among the features presented in the latest EMCDDA General Report of...
Alexis Goosdeel, EMCDDA Director

Impact of COVID-19 on the drug situation in Europe — EMCDDA Director presents findings to European Parliament

04.06.2020

Today, EMCDDA Director Alexis Goosdeel presented to the European Parliament the agency’s recent research findings on the impact of COVID-19 on the drug phenomenon in Europe.

New report provides window onto EU drug market changes during COVID-19

29.05.2020

What effect is COVID-19 having on the largest criminal market in the EU? This question is explored in EU Drug Markets: Impact of COVID-19, a new report out today from the EU drugs agency (EMCDDA) and...

New Zealand: referendum on cannabis legalisation to take place in September 2020

28.05.2020

Following an agreement made in 2017 between the ruling coalition parties in New Zealand, it has been announced that a referendum on legalising the recreational use of cannabis will be held together...
computer simulation of a Hep C virus

Testing for drug-related infectious diseases — a crucial step towards meeting international health goals

20.05.2020

Testing for drug-related infectious diseases among people who inject drugs (PWID) is crucial if international health targets are to be met. This is among the conclusions of a new EMCDDA report out...

COVID-19: New EMCDDA study highlights drop in availability of drug services in Europe but increase in innovation

12.05.2020

As Europe grapples with the unprecedented public health threat posed by COVID-19, how is the outbreak affecting drug users and service providers? In a new study published today — Impact of COVID-19...
depiction of circuit board

Increase in darknet market activity for cannabis as users stock up for lockdown

05.05.2020

The COVID-19 pandemic has profoundly impacted on our daily lives, including our behaviour as consumers. Just as we have seen online shopping for other goods increase during lockdowns, will we see a...
darknet icon

EMCDDA preparedness and response to a fast-moving drugs problem

30.04.2020

Revolutionary changes, both in the extent and nature of the drugs problem, and in the world in which we live, have called for constant reflection, innovation and agility to keep pace with new...

European Drugs Summer School 2020 to switch to remote teaching

23.04.2020

The European Drugs Summer School (EDSS) will switch to remote teaching this year in an effort to help curb the spread of COVID-19 and reduce pressure on health services.

EMCDDA launches COVID-19 special round of European Web Survey on Drugs to assess impact of pandemic

16.04.2020

Crucial information on the impact of COVID-19 on people who use drugs, and on the services that support them, will be collected via a special round of the European Web Survey on Drugs, launched this...
Screenshot of poster showing key events in the area of International cooperation from the EMCDDA's first 25 years (1995-2020)

25 years of monitoring — selected events from the EMCDDA’s international cooperation history

30.03.2020

Drugs have long been a cross-border phenomenon. As drug problems in Europe are increasingly linked to, and influenced by, global developments, it is crucial that our analysis of trends and...
Computer-generated simulation of a corona virus (copyrighted)

EMCDDA publishes update on the implications of COVID-19 for people who use drugs and for drug service providers

25.03.2020

What specific risks are people who use drugs (PWUD) likely to face during the COVID-19 pandemic? What services will they need? How will professionals working with this group need to adapt on the...
Croatian flag on blue sky background

EMCDDA offers its sympathies to earthquake-struck Croatia

23.03.2020

A large earthquake rocked Croatian capital Zagreb on 22 March, increasing the strain on the country’s emergency services, which are already challenged by the COVID-19 pandemic. The EMCDDA offers its...
Novel coronavirus viewed through an electron microscope

New COVID-19 precautionary measures: EMCDDA to switch to teleworking from 16 March 2020

16.03.2020

EMCDDA staff members will be switching to teleworking today following a decision by its Director Alexis Goosdeel (1). The decision comes as the COVID-19 pandemic continues to intensify and as the EU...

Latest wastewater data reveal drug-taking habits in 68 European cities — traces of stimulant drugs rise again

12.03.2020

The latest findings from the largest European project in the emerging science of wastewater analysis are presented today by the Europe-wide SCORE group, in association with the EU drugs agency (...
EU4MD networking photo

News from EU4Monitoring Drugs, an EMCDDA technical cooperation project

07.02.2020

This content was published in the third EU4MD update released on 07.02.2020. This update also presents a section on partnerships and related activities, upcoming events, and a research corner.

Bursaries for Western Balkan students for the 2020 European Drugs Summer School

06.02.2020

Professionals, academics and experts from the Western Balkan region will have an opportunity to participate in the European Drugs Summer School (EDSS) this year, thanks to three bursaries being...
25 year of drug monitoring (1995-2020)

A quarter of a century providing evidence for better policies and actions on drugs in Europe

30.01.2020

This year, the EMCDDA celebrates 25 years of monitoring the drug situation in Europe. In the quarter of a century since the agency embarked on its first work programme in 1995, we have seen...
logo european parliament

EMCDDA Director presents EU Drug Markets Report 2019 at European Parliament — ‘a clear wake-up call for policymakers’

28.01.2020

EMCDDA Director Alexis Goosdeel was at the European Parliament today, where he presented the findings of the EMCDDA–Europol EU Drug Markets Report 2019 (EDMR 2019) to the Committee on Civil Liberties...

EMCDDA and CICAD give seal of approval on latest joint work programme activities

21.01.2020

EMCDDA Director Alexis Goosdeel is in Washington today where he will meet Ambassador Adam Namm, Executive Secretary of the Inter-American Drug Abuse Control Commission (CICAD). The purpose of the...

Canada – edible cannabis products may now be sold in Canada

20.01.2020

From 16 December 2019, edible cannabis products are permitted to be sold in Canada. These must comply with new regulations for edible, inhalable and topical products, designed to reduce the risk of...
Loading